+Follow
琪琪小不点
No personal profile
49
Follow
23
Followers
0
Topic
0
Badge
Posts
Hot
琪琪小不点
2021-03-15
$Zomedica Pharmaceuticals Corp.(ZOM)$
???
琪琪小不点
2021-03-08
$Zomedica Pharmaceuticals Corp.(ZOM)$
???
琪琪小不点
2021-03-03
???
U.S. stock changes | Ocugen (OCGN.US) rose more than 40% before the market, and the medium-term effectiveness of the COVID-19 vaccine jointly developed with Bharat Biotech was 81%
琪琪小不点
2021-02-05
???
Sorry, the original content has been removed
Go to Tiger App to see more news
{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3566178813813075","uuid":"3566178813813075","gmtCreate":1603089103749,"gmtModify":1611910048661,"name":"琪琪小不点","pinyin":"qqxbdqiqixiaobudian","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/802429dbe105c6f967ebdfbdc5209819","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":23,"headSize":49,"tweetSize":170,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":38,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.52%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.24%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":322204758,"gmtCreate":1615807374874,"gmtModify":1704786792891,"author":{"id":"3566178813813075","authorId":"3566178813813075","name":"琪琪小不点","avatar":"https://static.tigerbbs.com/802429dbe105c6f967ebdfbdc5209819","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566178813813075","authorIdStr":"3566178813813075"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>???","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>???","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/322204758","isVote":1,"tweetType":1,"viewCount":2722,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":329805366,"gmtCreate":1615218140155,"gmtModify":1704779778414,"author":{"id":"3566178813813075","authorId":"3566178813813075","name":"琪琪小不点","avatar":"https://static.tigerbbs.com/802429dbe105c6f967ebdfbdc5209819","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566178813813075","authorIdStr":"3566178813813075"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>???","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>???","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/329805366","isVote":1,"tweetType":1,"viewCount":3197,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":365429140,"gmtCreate":1614772694980,"gmtModify":1704775019718,"author":{"id":"3566178813813075","authorId":"3566178813813075","name":"琪琪小不点","avatar":"https://static.tigerbbs.com/802429dbe105c6f967ebdfbdc5209819","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566178813813075","authorIdStr":"3566178813813075"},"themes":[],"htmlText":"???","listText":"???","text":"???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/365429140","repostId":"2116549921","repostType":2,"repost":{"id":"2116549921","kind":"news","pubTimestamp":1614771676,"share":"https://ttm.financial/m/news/2116549921?lang=en_US&edition=fundamental","pubTime":"2021-03-03 19:41","market":"us","language":"zh","title":"U.S. stock changes | Ocugen (OCGN.US) rose more than 40% before the market, and the medium-term effectiveness of the COVID-19 vaccine jointly developed with Bharat Biotech was 81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2116549921","media":"智通财经网","summary":"智通财经APP获悉，3月3日(周三)美股盘前，Ocugen(OCGN.US)股价飙升，截至北京时间19:40，该股涨42.68%，报13.64美元。此前，公司宣布与印度生物技术公司Bharat Biotech共同开发的新冠病毒疫苗中期有效性为81%。","content":"<p><html><body><article>Zhitong Finance APP learned that the share price of Ocugen (OCGN.US) soared before the U.S. stock market opened on March 3rd (Wednesday). As of 19:40 Beijing time, the stock rose 42.68% to $13.64. Previously, the company announced that the medium-term effectiveness of the new coronavirus vaccine jointly developed with Indian Biotech company Bharat Biotech was 81%.</p><p></article></body></html></p>","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. stock changes | Ocugen (OCGN.US) rose more than 40% before the market, and the medium-term effectiveness of the COVID-19 vaccine jointly developed with Bharat Biotech was 81%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. stock changes | Ocugen (OCGN.US) rose more than 40% before the market, and the medium-term effectiveness of the COVID-19 vaccine jointly developed with Bharat Biotech was 81%\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">智通财经网</strong><span class=\"h-time small\">2021-03-03 19:41</span>\n</p>\n</h4>\n</header>\n<article>\n<p><html><body><article>Zhitong Finance APP learned that the share price of Ocugen (OCGN.US) soared before the U.S. stock market opened on March 3rd (Wednesday). As of 19:40 Beijing time, the stock rose 42.68% to $13.64. Previously, the company announced that the medium-term effectiveness of the new coronavirus vaccine jointly developed with Indian Biotech company Bharat Biotech was 81%.</p><p></article></body></html></p>\n<div class=\"bt-text\">\n\n\n<p> source：<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202103031947097c066e42&s=b\">智通财经网</a></p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/e559c5a8390713a5a8d4b07a2667368d","relate_stocks":{"OCGN":"Ocugen"},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202103031947097c066e42&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2116549921","content_text":"智通财经APP获悉，3月3日(周三)美股盘前，Ocugen(OCGN.US)股价飙升，截至北京时间19:40，该股涨42.68%，报13.64美元。此前，公司宣布与印度生物技术公司Bharat Biotech共同开发的新冠病毒疫苗中期有效性为81%。","news_type":1,"symbols_score_info":{"OCGN":0.9}},"isVote":1,"tweetType":1,"viewCount":2589,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":380883531,"gmtCreate":1612532597623,"gmtModify":1704872472829,"author":{"id":"3566178813813075","authorId":"3566178813813075","name":"琪琪小不点","avatar":"https://static.tigerbbs.com/802429dbe105c6f967ebdfbdc5209819","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566178813813075","authorIdStr":"3566178813813075"},"themes":[],"htmlText":"???","listText":"???","text":"???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/380883531","repostId":"1170935467","repostType":4,"isVote":1,"tweetType":1,"viewCount":2540,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":329805366,"gmtCreate":1615218140155,"gmtModify":1704779778414,"author":{"id":"3566178813813075","authorId":"3566178813813075","name":"琪琪小不点","avatar":"https://static.tigerbbs.com/802429dbe105c6f967ebdfbdc5209819","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566178813813075","authorIdStr":"3566178813813075"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>???","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>???","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/329805366","isVote":1,"tweetType":1,"viewCount":3197,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":380883531,"gmtCreate":1612532597623,"gmtModify":1704872472829,"author":{"id":"3566178813813075","authorId":"3566178813813075","name":"琪琪小不点","avatar":"https://static.tigerbbs.com/802429dbe105c6f967ebdfbdc5209819","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566178813813075","authorIdStr":"3566178813813075"},"themes":[],"htmlText":"???","listText":"???","text":"???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/380883531","repostId":"1170935467","repostType":4,"isVote":1,"tweetType":1,"viewCount":2540,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":322204758,"gmtCreate":1615807374874,"gmtModify":1704786792891,"author":{"id":"3566178813813075","authorId":"3566178813813075","name":"琪琪小不点","avatar":"https://static.tigerbbs.com/802429dbe105c6f967ebdfbdc5209819","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566178813813075","authorIdStr":"3566178813813075"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>???","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>???","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/322204758","isVote":1,"tweetType":1,"viewCount":2722,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":365429140,"gmtCreate":1614772694980,"gmtModify":1704775019718,"author":{"id":"3566178813813075","authorId":"3566178813813075","name":"琪琪小不点","avatar":"https://static.tigerbbs.com/802429dbe105c6f967ebdfbdc5209819","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566178813813075","authorIdStr":"3566178813813075"},"themes":[],"htmlText":"???","listText":"???","text":"???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/365429140","repostId":"2116549921","repostType":2,"repost":{"id":"2116549921","kind":"news","pubTimestamp":1614771676,"share":"https://ttm.financial/m/news/2116549921?lang=en_US&edition=fundamental","pubTime":"2021-03-03 19:41","market":"us","language":"zh","title":"U.S. stock changes | Ocugen (OCGN.US) rose more than 40% before the market, and the medium-term effectiveness of the COVID-19 vaccine jointly developed with Bharat Biotech was 81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2116549921","media":"智通财经网","summary":"智通财经APP获悉，3月3日(周三)美股盘前，Ocugen(OCGN.US)股价飙升，截至北京时间19:40，该股涨42.68%，报13.64美元。此前，公司宣布与印度生物技术公司Bharat Biotech共同开发的新冠病毒疫苗中期有效性为81%。","content":"<p><html><body><article>Zhitong Finance APP learned that the share price of Ocugen (OCGN.US) soared before the U.S. stock market opened on March 3rd (Wednesday). As of 19:40 Beijing time, the stock rose 42.68% to $13.64. Previously, the company announced that the medium-term effectiveness of the new coronavirus vaccine jointly developed with Indian Biotech company Bharat Biotech was 81%.</p><p></article></body></html></p>","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. stock changes | Ocugen (OCGN.US) rose more than 40% before the market, and the medium-term effectiveness of the COVID-19 vaccine jointly developed with Bharat Biotech was 81%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. stock changes | Ocugen (OCGN.US) rose more than 40% before the market, and the medium-term effectiveness of the COVID-19 vaccine jointly developed with Bharat Biotech was 81%\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">智通财经网</strong><span class=\"h-time small\">2021-03-03 19:41</span>\n</p>\n</h4>\n</header>\n<article>\n<p><html><body><article>Zhitong Finance APP learned that the share price of Ocugen (OCGN.US) soared before the U.S. stock market opened on March 3rd (Wednesday). As of 19:40 Beijing time, the stock rose 42.68% to $13.64. Previously, the company announced that the medium-term effectiveness of the new coronavirus vaccine jointly developed with Indian Biotech company Bharat Biotech was 81%.</p><p></article></body></html></p>\n<div class=\"bt-text\">\n\n\n<p> source：<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202103031947097c066e42&s=b\">智通财经网</a></p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/e559c5a8390713a5a8d4b07a2667368d","relate_stocks":{"OCGN":"Ocugen"},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202103031947097c066e42&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2116549921","content_text":"智通财经APP获悉，3月3日(周三)美股盘前，Ocugen(OCGN.US)股价飙升，截至北京时间19:40，该股涨42.68%，报13.64美元。此前，公司宣布与印度生物技术公司Bharat Biotech共同开发的新冠病毒疫苗中期有效性为81%。","news_type":1,"symbols_score_info":{"OCGN":0.9}},"isVote":1,"tweetType":1,"viewCount":2589,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}
